Zoledronic Acid
NDC 68083-116, zoledronic acid, injection, solution, concentrate, from Gland Pharma Limited.
- Product NDC
- 68083-116
- Status
- Listed
- Labeler
- Gland Pharma Limited
- Dosage form
- INJECTION, SOLUTION, CONCENTRATE
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA202930
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/68083-116 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ZOLEDRONIC ACID4 mg/5mL
Pharmacologic classes
Bisphosphonate [EPC]; Diphosphonates [CS]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 68083-116-01 | 68083011601 | 1 VIAL in 1 CARTON (68083-116-01) / 5 mL in 1 VIAL |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/7a5e8962-7c4b-40bb-ad69-0c3edb0338af
Use it
Look up 68083-116 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/68083-116 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 68083-116. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.